Klára Gyires Selected Research

Klára Gyires Research Topics

Disease

9	Inflammation (Inflammations) 01/2023 - 06/2013
6	Pain (Aches) 01/2023 - 12/2007
5	Ulcer 08/2015 - 11/2011
4	Dysbiosis 01/2023 - 01/2019
2	Neuralgia (Stump Neuralgia) 01/2023 - 01/2019
2	Colitis 02/2017 - 01/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2017 - 01/2016
2	Visceral Pain 07/2013 - 09/2008
2	Hyperalgesia 10/2009 - 06/2007
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2023
1	Infarction (Infarctions) 01/2020
1	Reperfusion Injury 01/2020
1	Myocardial Infarction 01/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019
1	Hemorrhage 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Duodenal Ulcer (Curling's Ulcer) 08/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2014
1	Body Weight (Weight, Body) 01/2011
1	Thrombosis (Thrombus) 12/2009

Drug/Important Bio-Agent (IBA)

4	Opioid Analgesics (Opioids)IBA 01/2023 - 12/2007
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023 - 01/2016
4	Acetic Acid (Vinegar)FDA LinkGeneric 07/2013 - 06/2007
3	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2021
3	Ethanol (Ethyl Alcohol)IBA 02/2014 - 11/2011
2	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2021
2	rofecoxib (Vioxx)FDA Link 01/2020 - 01/2019
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020 - 01/2019
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019 - 01/2016
2	LigandsIBA 02/2017 - 01/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016 - 01/2014
2	EnzymesIBA 01/2016 - 06/2013
2	AcidsIBA 09/2014 - 11/2011
2	CarrageenanIBA 10/2009 - 06/2007
1	Caspase 3 (Caspase-3)IBA 10/2023
1	Therapeutic UsesIBA 01/2023
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2021
1	Claudin-1IBA 01/2021
1	KetorolacIBA 01/2021
1	Taurine FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2019
1	Opioid Receptors (Opioid Receptor)IBA 01/2019
1	SodiumIBA 02/2017
1	moxonidine (Moxon)IBA 02/2017
1	Rilmenidine (Hyperium)IBA 02/2017
1	Dextrans (Dextran)FDA Link 02/2017
1	ImidazolinesIBA 02/2017
1	Imidazoline ReceptorsIBA 02/2017
1	Drinking WaterIBA 02/2017
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016
1	EndocannabinoidsIBA 01/2016
1	Dextran SulfateIBA 01/2016
1	Chemokine CXCL2IBA 01/2016
1	Chemokine CCL3IBA 01/2016
1	CannabinoidsIBA 01/2016
1	BRL 44408IBA 01/2016
1	Clonidine (ST 155)FDA LinkGeneric 01/2016
1	Dopamine (Intropin)FDA LinkGeneric 08/2015
1	SteroidsIBA 08/2015
1	Hormones (Hormone)IBA 08/2015
1	AgmatineIBA 09/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Epidermal Growth Factor (EGF)IBA 01/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2014
1	CytokinesIBA 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	salicylhydroxamic acid (SHAM)IBA 07/2013
1	Analgesics (Analgesic Drugs)IBA 07/2013
1	N'-(2-phenylallyl)hydrazineIBA 06/2013
1	human AOC3 proteinIBA 06/2013
1	3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oximeIBA 06/2013
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 06/2013
1	Oxymetazoline FDA Link 11/2011
1	Blood Glucose (Blood Sugar)IBA 01/2011
1	Hypnotics and Sedatives (Sedatives)IBA 12/2009
1	diprotin AIBA 10/2009
1	Morphine (MS Contin)FDA LinkGeneric 06/2009
1	resiniferatoxinIBA 06/2007
1	Capsaicin (Zostrix)FDA Link 06/2007
1	Formaldehyde (Formol)FDA Link 06/2007

Therapy/Procedure

3	Intraperitoneal Injections 07/2013 - 09/2008
2	Analgesia 01/2019 - 12/2007
1	Therapeutics 01/2014